欢迎访问行业研究报告数据库

行业分类

当前位置:首页 > 报告详细信息

找到报告 1 篇 当前为第 1 页 共 1

全球生物仿制药合同制造展望预测市场(2022-2027年)

Global Biosimilar Contract Manufacturing Market - Global Outlook Forecast 2022-2027

加工时间:2023-04-24 信息来源:EMIS 索取原文[306 页]
关键词:药物;生活质量;生物仿制药;结构和功能
摘 要:

More than 2 billion people worldwide are not able to afford life-saving medicines, which puts their lives at risk. The rise in the development and commercialization of potentially life-saving drugs has made them more accessible and affordable. Also, the ease of accessibility to pharmaceutical drugs has minimized health inequality and enabled patients to live a better quality of life for a prolonged period. Although biologic drugs are at the forefront of therapeutic developments, their high-cost accounts for a significant portion of public and private drug expenditure worldwide. Comparatively, biosimilars are quite close in structure and function to biologic drugs and can prove to be more sustainable solutions at an affordable cost.


目 录:

1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

4 SCOPE & COVERAGE

5 REPORT ASSUMPTIONS & CAVEATS

6 MARKET AT A GLANCE

7 INTRODUCTION

8 PREMIUM INSIGHTS

9 MARKET OPPORTUNITIES & TRENDS

10 MARKET GROWTH ENABLERS


© 2016 武汉世讯达文化传播有限责任公司 版权所有 技术支持:武汉中网维优
客服中心

QQ咨询


点击这里给我发消息 客服员


电话咨询


027-87841330


微信公众号




展开客服